Pre-operative classification of molar pregnancy: How good is ultrasound?
early pregnancy
gestational trophoblastic disease
miscarriage
molar pregnancy
transvaginal ultrasound
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
09
12
2018
accepted:
09
01
2020
pubmed:
19
2
2020
medline:
13
2
2021
entrez:
19
2
2020
Statut:
ppublish
Résumé
Histopathology is the reference standard for diagnosing hydatidiform molar pregnancy (HMP). To assess the performance of pre-operative transvaginal ultrasound (TVS) to predict HMP. A retrospective diagnostic accuracy study was performed on women who had both TVS and histopathological examination of uterine curettings between January 2011-February 2017. TVS diagnosis of partial MP (PMP) included assessment of fetal parts and/or empty gestational sac with small cystic spaces adjacent to gestational sac. TVS diagnosis of complete MP (CMP) included assessment of complex, echogenic intra-uterine mass(es) containing multiple small cystic areas. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive and negative likelihood ratios (PLR/NLR) for TVS were reported. Reference standard was histology. There were 4917 consecutive women who underwent TVS; 1636 underwent surgical curettage for miscarriage. Forty out of 4917 (0.6%) had HMP histologically; 25/40 (62.5%) had suspected HMP and 15/40 (37.5%) did not; 24/40 (60.0%) had CMP of which 19/24 (79.1%) were suspected on TVS and 5/24 (20.8%) were not; 16/40 (40.0%) had PMP of which 6/16 (37.5%) were suspected on TVS and 10/16 (62.6%) were not. The sensitivity, specificity, PPV, NPV, PLR and NLR of pre-operative TVS to predict HMP were: 60.0, 99.1, 63.2, 99.0% 68.4, 0.4; for CMP: 79.2, 99.8, 86.3, 99.6%, 421.7, 0.2; for PMP: 37.5, 99.3, 35.3, 99.4%, 54.3, 0.6. Histology remains the gold standard for diagnosing HMP. TVS is an acceptable diagnostic tool for HMP. When there are no ultrasound features of HMP, almost all these women will not have an underlying HMP.
Sections du résumé
BACKGROUND
Histopathology is the reference standard for diagnosing hydatidiform molar pregnancy (HMP).
AIM
To assess the performance of pre-operative transvaginal ultrasound (TVS) to predict HMP.
MATERIALS AND METHODS
A retrospective diagnostic accuracy study was performed on women who had both TVS and histopathological examination of uterine curettings between January 2011-February 2017. TVS diagnosis of partial MP (PMP) included assessment of fetal parts and/or empty gestational sac with small cystic spaces adjacent to gestational sac. TVS diagnosis of complete MP (CMP) included assessment of complex, echogenic intra-uterine mass(es) containing multiple small cystic areas. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive and negative likelihood ratios (PLR/NLR) for TVS were reported. Reference standard was histology.
RESULTS
There were 4917 consecutive women who underwent TVS; 1636 underwent surgical curettage for miscarriage. Forty out of 4917 (0.6%) had HMP histologically; 25/40 (62.5%) had suspected HMP and 15/40 (37.5%) did not; 24/40 (60.0%) had CMP of which 19/24 (79.1%) were suspected on TVS and 5/24 (20.8%) were not; 16/40 (40.0%) had PMP of which 6/16 (37.5%) were suspected on TVS and 10/16 (62.6%) were not. The sensitivity, specificity, PPV, NPV, PLR and NLR of pre-operative TVS to predict HMP were: 60.0, 99.1, 63.2, 99.0% 68.4, 0.4; for CMP: 79.2, 99.8, 86.3, 99.6%, 421.7, 0.2; for PMP: 37.5, 99.3, 35.3, 99.4%, 54.3, 0.6.
CONCLUSION
Histology remains the gold standard for diagnosing HMP. TVS is an acceptable diagnostic tool for HMP. When there are no ultrasound features of HMP, almost all these women will not have an underlying HMP.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
698-703Informations de copyright
© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Royal College of Obstetricians and Gynaecologists. The Management of Gestational Trophoblastic Disease. RCOG Greentop. London: RCOG, 2010.
Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol 2003; 6: 69-77.
Jain KA. Gestational trophoblastic disease. Ultrasound Q 2005; 21: 245-253.
Thomas CMG, Kerkmeijer LGW, Massuger LFAG, ten Kate-Booij MJ, Sweep FCGJ. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol. 2009; 113: 326-331.
Kirk E, Papageorghiou AT, Condous G, Bottomley C, Bourne T. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole. Ultrasound Obstet Gynecol 2007; 29: 70-75.
Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med 1996; 335(23): 1740-1748.
Cohen JF, Korevaar DA, Altman DG et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 2016; 6: e012799.
Sebire NJ, Rees H, Paradinas F, Seckl M, Newlands E. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol 2001; 18(6): 662-665.
Shah C, Johnson PT, Durrani H. SONOWORLD : Partial molar pregnancy, 2018. [Accessed 26 June 2018.] Available from URL: https://sonoworld.com/CaseDetails/Partial_molar_pregnancy.aspx?ModuleCategoryId=306
Johns J, Greenwold N, Buckley S, Jauniaux E. A prospective study of ultrasound screening for molar pregnancies in missed miscarriages. Ultrasound Obstet Gynecol 2005; 25: 493-497.
John Hopkins Medicine- Pathology 2002-2019 Pathology of Gestational Trophoblastic Lesions. [Accessed 26 June 2018.] Available from URL: http://pathology.jhu.edu/trophoblast/hydat.cfm
Genest DR. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 2001; 20: 315-322.
Lindholm H, Flam F. The diagnosis of molar pregnancy by sonography and gross morphology. Acta Obstet Gynecol Scand 1999; 78: 6-9.
Sebire NJ, Seckl MJ. Gestational trophoblastic disease: current management of hydatidiform mole. BMJ 2008; 337: a1193-a1193.
Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: Experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 2006; 27: 56-60.